Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MALT1 | Q9UDY8 | 2/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22965236 | 0.89 | CNR1 (0.38) | PTPN1HSP90AA1CNR1CNR2MAPT | |
| SCHEMBL21454602 | 0.82 | MALT1 (0.37) | PTPN1HSP90AA1CNR2MAPTPLCG2 | |
| SCHEMBL22965225 | 0.81 | PTPN1 (0.47) | PTPN1HSP90AA1 | |
| SCHEMBL21454558 | 0.81 | CNR1 (0.38) | PTPN1HSP90AA1CNR1CNR2MAPT | |
| SCHEMBL22965224 | 0.77 | PTPN1 (0.37) | PTPN1 | |
| SCHEMBL22965205 | 0.75 | MALT1 (0.37) | PTPN1HSP90AA1CNR2MAPTPLCG2 | |
| SCHEMBL22965252 | 0.73 | PTPN1 (0.43) | PTPN1HSP90AA1 | |
| SCHEMBL21454331 | 0.73 | CNR2 (0.35) | PTPN1HSP90AA1CNR1CNR2 | |
| SCHEMBL23017896 | 0.69 | CNR2 (0.33) | PTPN1HSP90AA1CNR1CNR2 | |
| SCHEMBL22947214 | 0.67 | HSP90AA1 (0.42) | HSP90AA1MAPTPLCG2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040106-A1 | METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE | Glaceum Inc. (KR) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040106-A1 | METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE | HPD, CYP2J2, PAH | PTPN1 2837/4885HSP90AA1 3318/4885CNR1 1750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.